On the public citation graph

Designing Multitarget Anti‐inflammatory Agents: Chemical Modulation of the Lumiracoxib Structure toward Dual Thromboxane Antagonists–COX‐2 Inhibitors

https://doi.org/10.1002/cmdc.201200272

0 signed · 80 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/cbdv.200900421openalex-snapshot

Nitrooxymethyl‐Substituted Analogues of Rofecoxib: Synthesis and Pharmacological Characterization

inferredcites →https://doi.org/10.1002/cbic.200800600openalex-snapshot

Development and Biological Evaluation of a Novel Aurora A Kinase Inhibitor

inferredcites →https://doi.org/10.1002/cmdc.201100393openalex-snapshot

Rofecoxib Analogues Possessing a Nitric Oxide Donor Sulfohydroxamic Acid (SO2NHOH) Cyclooxygenase‐2 Pharmacophore: Synthesis, Molecular Modeling, and Biological Evaluation as Anti‐inflammatory Agents

inferredcites →https://doi.org/10.1007/s00018-010-0368-9openalex-snapshot

Superactive mutants of thromboxane prostanoid receptor: functional and computational analysis of an active form alternative to constitutively active mutants

inferredcites →https://doi.org/10.1016/0002-9343(89)90344-6openalex-snapshot

Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage

inferredcites →https://doi.org/10.1016/0003-2697(80)90515-1openalex-snapshot

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

inferredcites →https://doi.org/10.1016/j.tet.2004.09.064openalex-snapshot

Synthesis of new N-aryl oxindoles as intermediates for pharmacologically active compounds

inferredcites →https://doi.org/10.1016/j.tibs.2007.09.013openalex-snapshot

Nutritionally essential fatty acids and biologically indispensable cyclooxygenases

inferredcites →https://doi.org/10.1016/j.tips.2009.11.007openalex-snapshot

Dual COXIB/TP antagonists: a possible new twist in NSAID pharmacology and cardiovascular risk

inferredcites →https://doi.org/10.1016/s0022-3565(24)38195-9openalex-snapshot

Effects of Specific Inhibition of Cyclooxygenase-2 on Sodium Balance, Hemodynamics, and Vasoactive Eicosanoids

inferredcites →https://doi.org/10.1016/s0079-6468(08)70048-1openalex-snapshot

5 Selective Inhibitors of Cyclooxygenase-2 (COT-2)

inferredcites →https://doi.org/10.1016/s0090-6980(02)00029-1openalex-snapshot

Distinct functions of COX-1 and COX-2

inferredcites →https://doi.org/10.1016/s0140-6736(08)60137-3openalex-snapshot

COX-2 selectivity alone does not define the cardiovascular risks associated with non-steroidal anti-inflammatory drugs

inferredcites →https://doi.org/10.1016/s0140-6736(11)60600-4openalex-snapshot

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial

inferredcites →https://doi.org/10.1016/s0165-6147(98)01242-5openalex-snapshot

Ligand-binding studies: old beliefs and new strategies

inferredcites →https://doi.org/10.1021/ac00049a010openalex-snapshot

pH-Metric log P. 3. Glass electrode calibration in methanol-water, applied to pKa determination of water-insoluble substances

inferredcites →https://doi.org/10.1021/cr200008nopenalex-snapshot

Nitric Oxide: A Guardian for Vascular Grafts?

inferredcites →https://doi.org/10.1021/cr950066qopenalex-snapshot

Bioisosterism: A Rational Approach in Drug Design

inferredcites →https://doi.org/10.1021/jm030276sopenalex-snapshot

Synthesis and Selective Cyclooxygenase-2 Inhibitory Activity of a Series of Novel, Nitric Oxide Donor-Containing Pyrazoles

inferredcites →https://doi.org/10.1021/jm0402059openalex-snapshot

Adverse Cardiovascular Effects of the Coxibs

inferredcites →https://doi.org/10.1021/jm058225dopenalex-snapshot

Designed Multiple Ligands. An Emerging Drug Discovery Paradigm

inferredcites →https://doi.org/10.1021/jm0607247openalex-snapshot

NO-Donor COX-2 Inhibitors. New Nitrooxy-Substituted 1,5-Diarylimidazoles Endowed with COX-2 Inhibitory and Vasodilator Properties

inferredcites →https://doi.org/10.1021/jm0613166openalex-snapshot

Structural and Functional Basis of Cyclooxygenase Inhibition

inferredcites →https://doi.org/10.1021/jm200715nopenalex-snapshot

Novel Analgesic/Anti-Inflammatory Agents: Diarylpyrrole Acetic Esters Endowed with Nitric Oxide Releasing Properties

inferredcites →https://doi.org/10.1021/jm200980uopenalex-snapshot

Cyclopentane-1,3-dione: A Novel Isostere for the Carboxylic Acid Functional Group. Application to the Design of Potent Thromboxane (A2) Receptor Antagonists

inferredcites →https://doi.org/10.1038/sj.bjp.0707518openalex-snapshot

Antagonism of thromboxane receptors by diclofenac and lumiracoxib

inferredcites →https://doi.org/10.1042/0300-5127:0290641openalex-snapshot

Thromboxane A2 Signalling in Humans: a ‘Tail’ of Two Receptors

inferredcites →https://doi.org/10.1055/s-0030-1258379openalex-snapshot

Copper-Promoted Carbon-Heteroatom Bond Cross-Coupling with Boronic Acids and Derivatives

inferredcites →https://doi.org/10.1056/nejm199906173402407openalex-snapshot

Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs

inferredcites →https://doi.org/10.1056/nejmp048288openalex-snapshot

Coxibs and Cardiovascular Disease

inferredcites →https://doi.org/10.1073/pnas.96.1.272openalex-snapshot

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2

inferredcites →https://doi.org/10.1074/jbc.274.5.2645openalex-snapshot

Phosphorylation of the Thromboxane Receptor α, the Predominant Isoform Expressed in Human Platelets

inferredcites →https://doi.org/10.1074/jbc.m305481200openalex-snapshot

A Novel Mechanism of Cyclooxygenase-2 Inhibition Involving Interactions with Ser-530 and Tyr-385

inferredcites →https://doi.org/10.1096/fj.05-4434fjeopenalex-snapshot

Influence of plasma protein on the potencies of inhibitors of cyclooxygenase‐1 and ‐2

inferredcites →https://doi.org/10.1111/j.1440-1746.2009.05929.xopenalex-snapshot

Rescue strategies against non‐steroidal anti‐inflammatory drug‐induced gastroduodenal damage

inferredcites →https://doi.org/10.1111/j.1440-1746.2011.07036.xopenalex-snapshot

Severe acute liver injury associated with lumiracoxib

inferredcites →https://doi.org/10.1111/j.1476-5381.1981.tb16814.xopenalex-snapshot

COMPARISON OF THE ACTIONS OF U‐46619, A PROSTAGLANDIN H2‐ANALOGUE, WITH THOSE OF PROSTAGLANDIN H2 AND THROMBOXANE A2 ON SOME ISOLATED SMOOTH MUSCLE PREPARATIONS

inferredcites →https://doi.org/10.1111/j.2042-7158.2006.tb01645.xopenalex-snapshot

Assessment and prevention of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs

inferredcites →https://doi.org/10.1113/jphysiol.1963.sp007185openalex-snapshot

The aggregation of blood platelets

inferredcites →https://doi.org/10.1124/mol.104.001487openalex-snapshot

Mutational Analysis of the Highly Conserved ERY Motif of the Thromboxane A2 Receptor: Alternative Role in G Protein-Coupled Receptor Signaling

inferredcites →https://doi.org/10.1124/pr.110.003517openalex-snapshot

International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress

inferredcites →https://doi.org/10.1136/bmj.332.7553.1302openalex-snapshot

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

inferredcites →https://doi.org/10.1136/bmj.c7086openalex-snapshot

Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis

inferredcites →https://doi.org/10.1146/annurev.biochem.69.1.145openalex-snapshot

Cyclooxygenases: Structural, Cellular, and Molecular Biology

inferredcites →https://doi.org/10.1161/circulationaha.105.568451openalex-snapshot

Cyclooxygenase Inhibition and Cardiovascular Risk

inferredcites →https://doi.org/10.1172/jci27291openalex-snapshot

Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities

inferredcites →https://doi.org/10.2174/1389557043403693openalex-snapshot

First and Second Generations of COX-2 Selective Inhibitors

inferredcites →https://doi.org/10.2174/138955708783331577openalex-snapshot

Current Status of COX-2 Inhibitors

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4524815openalex-extracted

inferred← citeshttps://doi.org/10.1002/0471266949.bmc284openalex-snapshot

Eicosanoid Pathway Modulators: Prostaglandins, Prostacyclin, and Thromboxane

inferred← citeshttps://doi.org/10.1002/cmdc.202000258openalex-snapshot

Polysubstituted Pyrimidines as mPGES‐1 Inhibitors: Discovery of Potent Inhibitors of PGE2 Production with Strong Anti‐inflammatory Effects in Carrageenan‐Induced Rat Paw Edema

inferred← citeshttps://doi.org/10.1002/med.21331openalex-snapshot

Recent Developments in Chimeric NSAIDs as Safer Anti‐Inflammatory Agents

inferred← citeshttps://doi.org/10.1007/978-3-030-50621-6_3openalex-snapshot

Druggable Prostanoid Pathway

inferred← citeshttps://doi.org/10.1007/s00044-020-02528-1openalex-snapshot

Selective cyclooxygenase-2 inhibitors: A review of recent chemical scaffolds with promising anti-inflammatory and COX-2 inhibitory activities

inferred← citeshttps://doi.org/10.1007/s00894-018-3620-0openalex-snapshot

Molecular docking, molecular modeling, and molecular dynamics studies of azaisoflavone as dual COX-2 inhibitors and TP receptor antagonists

inferred← citeshttps://doi.org/10.1007/s11883-015-0514-9openalex-snapshot

Prostanoids and NSAIDs in Cardiovascular Biology and Disease

inferred← citeshttps://doi.org/10.1007/s42823-023-00603-2openalex-snapshot

Design, synthesis and biological studies of tetrazole fused imidazopyridines

inferred← citeshttps://doi.org/10.1016/j.advms.2017.06.004openalex-snapshot

A systematic review on the role of eicosanoid pathways in rheumatoid arthritis

inferred← citeshttps://doi.org/10.1016/j.bcp.2018.10.007openalex-snapshot

Two-pronged approach to anti-inflammatory therapy through the modulation of the arachidonic acid cascade

inferred← citeshttps://doi.org/10.1016/j.bioorg.2022.105663openalex-snapshot

Inflammation: Biochemistry, cellular targets, anti-inflammatory agents and challenges with special emphasis on cyclooxygenase-2

inferred← citeshttps://doi.org/10.1016/j.cclet.2013.05.026openalex-snapshot

Synthesis of tetrazole containing 1,2,3-thiadiazole derivatives via U-4CR and their anti-TMV activity

inferred← citeshttps://doi.org/10.1016/j.cdc.2023.101092openalex-snapshot

Synthesis and biological evaluation of tetrazole fused imidazopyridine derivatives as anticancer agents

inferred← citeshttps://doi.org/10.1016/j.ejmech.2023.115542openalex-snapshot

Discovery of a novel 1,3,4-oxadiazol-2-one-based NLRP3 inhibitor as a pharmacological agent to mitigate cardiac and metabolic complications in an experimental model of diet-induced metaflammation

inferred← citeshttps://doi.org/10.1016/j.insi.2026.100343openalex-snapshot

Computational exploration of N-Aryl-3-acylindole derivatives targeting COX-2 and the thromboxane A₂ receptor

inferred← citeshttps://doi.org/10.1016/j.phrs.2015.11.012openalex-snapshot

In vitro pharmacological evaluation of multitarget agents for thromboxane prostanoid receptor antagonism and COX-2 inhibition

inferred← citeshttps://doi.org/10.1016/j.prostaglandins.2015.04.003openalex-snapshot

A potential role of PUFAs and COXIBs in cancer chemoprevention

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5c02068openalex-snapshot

Exploiting the 2-(1,3,4,9-tetrahydropyrano[3,4- b ]indol-1-yl)acetic Acid Scaffold to Generate COXTRANs: A New Class of Dual Cyclooxygenase Inhibitors-Thromboxane Receptor Antagonists

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.8b00760openalex-snapshot

Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.9b00445openalex-snapshot

Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain

inferred← citeshttps://doi.org/10.1021/acs.joc.5b01074openalex-snapshot

Selective Formation of ortho -Aminobenzylamines by the Copper-Catalyzed Amination of Benzylamine Boronate Esters

inferred← citeshttps://doi.org/10.1021/acsomega.0c04942openalex-snapshot

Development of Novel Diclofenac Analogs Designed to Avoid Metabolic Activation and Hepatocyte Toxicity

inferred← citeshttps://doi.org/10.1039/c6md00569aopenalex-snapshot

Structure–activity relationships for the synthesis of selective cyclooxygenase 2 inhibitors: an overview (2009–2016)

inferred← citeshttps://doi.org/10.1080/00397911.2024.2331922openalex-snapshot

Synthesis and biological evaluation of tetrazole ring incorporated oxazole-pyrimidine derivatives as anticancer agents

inferred← citeshttps://doi.org/10.1111/bcpt.12134openalex-snapshot

Inhibitors of the Arachidonic Acid Cascade: Interfering with Multiple Pathways

inferred← citeshttps://doi.org/10.1134/s1070363218100250openalex-snapshot

Design, Synthesis, and Anticancer Evaluation of Tetrazole-Fused Benzoxazole Derivatives as Tubulin Binding Agents

inferred← citeshttps://doi.org/10.1155/2014/120173openalex-snapshot

Synthesis, Spectral Analysis, In Vitro Microbiological Evaluation, and Molecular Docking Studies of Some Novel 1-(1-Aryl-1H-tetrazol-5-yl)-2-(piperidin-1-yl)ethanone Derivatives

inferred← citeshttps://doi.org/10.2174/0929867324666170602083428openalex-snapshot

Nonsteroidal Anti-Inflammatory Drugs: Exploiting Bivalent COXIB/ TP Antagonists for the Control of Cardiovascular Risk

inferred← citeshttps://doi.org/10.3892/mmr.2017.7655openalex-snapshot

Dipterocarpus obtusifolius attenuates the effects of lipopolysaccharide-induced inflammatory response in RAW264.7 macrophages

inferred← citeshttps://doi.org/10.4155/fmc-2018-0159openalex-snapshot

Introduction to COX Inhibitors

inferred← citeshttps://doi.org/10.4155/fmc-2023-0192openalex-snapshot

Dual-Target Inhibitors Based on COX-2: A Review from Medicinal Chemistry Perspectives

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.